EARLY CHILDHOOD INFECTION WITH HUMAN HERPES VIRUS TYPE 6 (HHV-6) AS A PROTECTION AGAINST THE DEVELOPMENT OF IGE SENSITIZATION, ATOPIC DISEASE AND ALLERGY IN YOUNG CHILDREN
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Mar 19, 2007
filing date -
Sep 17, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention discloses a use of human herpes virus 6 (HHV-6) or derivatives thereof, for the manufacture of a pharmaceutical composition intended to be administered during early childhood, for the prevention of IgE sensitization and allergy development in young children. Examples of viral compositions include, but are not limited to live human herpes virus 6 (HHV-6).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully